Average Co-Inventor Count = 5.98
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Genentech, Inc. (22 from 3,224 patents)
2. Other (15 from 832,966 patents)
3. Myokardia, Inc. (8 from 12 patents)
4. 3-V Biosciences, Inc. (8 from 10 patents)
5. Hoechst Aktiengesellschaft (4 from 6,662 patents)
6. Leland Stanford Junior University (4 from 5,317 patents)
7. Aventis Pharma S.a. (4 from 377 patents)
8. Sunesis Pharmaceuticals, Inc. (3 from 63 patents)
9. The University of Texas System (2 from 5,468 patents)
10. Hoechst Marion Roussel (2 from 236 patents)
11. Sanofi-A Ventis Deutschland Gmbh (1 from 1,832 patents)
12. Aventis Pharma Deutschland, Gmbh (1 from 330 patents)
13. Saginiet Biosciences Inc. (1 from 1 patent)
14. Sagimet Biosciences Inc. (1 from 1 patent)
69 patents:
1. RE50050 - Pyrimidinedione compounds
2. 11622968 - Heterocyclic modulators of lipid synthesis
3. 11123337 - 4-methylsulfonyl-substituted piperidine urea compounds
4. 11034690 - Heterocyclic modulators of lipid synthesis
5. 10758525 - 4-methylsulfonyl-substituted piperidine urea compounds
6. 10226449 - Heterocyclic modulators of lipid synthesis and combinations thereof
7. 10189822 - Heterocyclic modulators of lipid synthesis
8. 10118913 - Heterocyclic modulators of lipid synthesis
9. 10053450 - Heterocyclic modulators of lipid synthesis
10. 9925177 - 4-methylsulfonyl-substituted piperidine urea compounds
11. 9809591 - Heterocyclic modulators of lipid synthesis
12. 9663516 - Bicyclic-pyrimidinedione compounds
13. 9624173 - Heterocyclic modulators of lipid synthesis
14. 9585883 - Pyrimidinedione compounds
15. 9428502 - Heterocyclic modulators of lipid synthesis